Michael Kenison Sells 200 Shares of Proto Labs (NYSE:PRLB) Stock

Proto Labs, Inc. (NYSE:PRLB) insider Michael Kenison sold 200 shares of the stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $70.00, for a total value of $14,000.00. Following the sale, the insider owned 27,186 shares in the company, valued at $1,903,020. The trade was a 0.73% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Proto Labs Price Performance

Shares of PRLB stock traded up $0.95 during trading hours on Friday, hitting $69.12. 141,543 shares of the company’s stock were exchanged, compared to its average volume of 177,960. The stock’s 50-day moving average is $60.55 and its 200-day moving average is $56.28. The stock has a market cap of $1.64 billion, a price-to-earnings ratio of 65.21 and a beta of 1.36. Proto Labs, Inc. has a 52 week low of $36.15 and a 52 week high of $70.00.

Proto Labs (NYSE:PRLB) last announced its earnings results on Friday, May 1st. The industrial products company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. The company had revenue of $139.34 million for the quarter, compared to analysts’ expectations of $135.31 million. Proto Labs had a return on equity of 4.15% and a net margin of 4.71%.The business’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.33 earnings per share. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. Equities research analysts forecast that Proto Labs, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on PRLB shares. Zacks Research cut Proto Labs from a “strong-buy” rating to a “hold” rating in a report on Friday, April 10th. Weiss Ratings upgraded Proto Labs from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $53.33.

Hedge Funds Weigh In On Proto Labs

Hedge funds have recently added to or reduced their stakes in the company. Group One Trading LLC bought a new position in Proto Labs in the fourth quarter valued at about $25,000. NewEdge Advisors LLC boosted its holdings in Proto Labs by 7,380.0% in the first quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock valued at $26,000 after acquiring an additional 738 shares during the last quarter. NBC Securities Inc. bought a new position in Proto Labs in the fourth quarter valued at about $46,000. Modus Advisors LLC bought a new position in Proto Labs in the fourth quarter valued at about $57,000. Finally, Aquatic Capital Management LLC bought a new position in Proto Labs in the third quarter valued at about $64,000. Institutional investors own 84.54% of the company’s stock.

Proto Labs Company Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.